Global AAV-based Gene Therapy Products Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 136

Published Date: 28 Apr 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

AAV-based gene therapy products utilize adeno-associated virus (AAV) vectors as delivery vehicles to transfer therapeutic genes into target cells for the treatment of various genetic disorders and diseases. AAV vectors are non-pathogenic viruses that can efficiently infect a wide range of cells and have a low immunogenicity profile, making them suitable candidates for gene therapy applications. In AAV-based gene therapy, the therapeutic gene of interest is inserted into the AAV vector's genome, and the vector is then administered to the patient, typically via intravenous injection or direct injection into the affected tissue. Once inside the target cells, the AAV vector delivers the therapeutic gene, allowing it to be expressed and produce the desired therapeutic protein. AAV-based gene therapy products hold significant promise for the treatment of inherited genetic disorders, as well as acquired diseases such as certain types of cancer and neurodegenerative disorders, offering potential long-term therapeutic benefits with a single administration.

According to our (Global Info Research) latest study, the global AAV-based Gene Therapy Products market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global AAV-based Gene Therapy Products market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global AAV-based Gene Therapy Products market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global AAV-based Gene Therapy Products market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global AAV-based Gene Therapy Products market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global AAV-based Gene Therapy Products market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AAV-based Gene Therapy Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AAV-based Gene Therapy Products market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include uniQure, Spark Therapeutics, AveXis (Novartis), PTC Therapeutics, BioMarin, Sarepta Therapeutics, Roche, Pfizer, CSL Behring, Sangamo Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
AAV-based Gene Therapy Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    AAV2
    AAV8
    AAV9
    Others

Market segment by Application
    Haematology
    Ophthalmology
    Neurology
    Musculoskeletal
    Others

Major players covered
    uniQure
    Spark Therapeutics
    AveXis (Novartis)
    PTC Therapeutics
    BioMarin
    Sarepta Therapeutics
    Roche
    Pfizer
    CSL Behring
    Sangamo Therapeutics
    Biogen
    Freeline Therapeutics
    Coave Therapeutics
    MeiraGTx
    RegenxBio
    Asklepios Biopharmaceutical
    Audentes Therapeutics
    Neurophth
    Belief BioMed

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe AAV-based Gene Therapy Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of AAV-based Gene Therapy Products, with price, sales quantity, revenue, and global market share of AAV-based Gene Therapy Products from 2019 to 2024.
Chapter 3, the AAV-based Gene Therapy Products competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the AAV-based Gene Therapy Products breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and AAV-based Gene Therapy Products market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of AAV-based Gene Therapy Products.
Chapter 14 and 15, to describe AAV-based Gene Therapy Products sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global AAV-based Gene Therapy Products Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 AAV2
        1.3.3 AAV8
        1.3.4 AAV9
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global AAV-based Gene Therapy Products Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Haematology
        1.4.3 Ophthalmology
        1.4.4 Neurology
        1.4.5 Musculoskeletal
        1.4.6 Others
    1.5 Global AAV-based Gene Therapy Products Market Size & Forecast
        1.5.1 Global AAV-based Gene Therapy Products Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global AAV-based Gene Therapy Products Sales Quantity (2019-2030)
        1.5.3 Global AAV-based Gene Therapy Products Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 uniQure
        2.1.1 uniQure Details
        2.1.2 uniQure Major Business
        2.1.3 uniQure AAV-based Gene Therapy Products Product and Services
        2.1.4 uniQure AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 uniQure Recent Developments/Updates
    2.2 Spark Therapeutics
        2.2.1 Spark Therapeutics Details
        2.2.2 Spark Therapeutics Major Business
        2.2.3 Spark Therapeutics AAV-based Gene Therapy Products Product and Services
        2.2.4 Spark Therapeutics AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Spark Therapeutics Recent Developments/Updates
    2.3 AveXis (Novartis)
        2.3.1 AveXis (Novartis) Details
        2.3.2 AveXis (Novartis) Major Business
        2.3.3 AveXis (Novartis) AAV-based Gene Therapy Products Product and Services
        2.3.4 AveXis (Novartis) AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 AveXis (Novartis) Recent Developments/Updates
    2.4 PTC Therapeutics
        2.4.1 PTC Therapeutics Details
        2.4.2 PTC Therapeutics Major Business
        2.4.3 PTC Therapeutics AAV-based Gene Therapy Products Product and Services
        2.4.4 PTC Therapeutics AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 PTC Therapeutics Recent Developments/Updates
    2.5 BioMarin
        2.5.1 BioMarin Details
        2.5.2 BioMarin Major Business
        2.5.3 BioMarin AAV-based Gene Therapy Products Product and Services
        2.5.4 BioMarin AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 BioMarin Recent Developments/Updates
    2.6 Sarepta Therapeutics
        2.6.1 Sarepta Therapeutics Details
        2.6.2 Sarepta Therapeutics Major Business
        2.6.3 Sarepta Therapeutics AAV-based Gene Therapy Products Product and Services
        2.6.4 Sarepta Therapeutics AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Sarepta Therapeutics Recent Developments/Updates
    2.7 Roche
        2.7.1 Roche Details
        2.7.2 Roche Major Business
        2.7.3 Roche AAV-based Gene Therapy Products Product and Services
        2.7.4 Roche AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Roche Recent Developments/Updates
    2.8 Pfizer
        2.8.1 Pfizer Details
        2.8.2 Pfizer Major Business
        2.8.3 Pfizer AAV-based Gene Therapy Products Product and Services
        2.8.4 Pfizer AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Pfizer Recent Developments/Updates
    2.9 CSL Behring
        2.9.1 CSL Behring Details
        2.9.2 CSL Behring Major Business
        2.9.3 CSL Behring AAV-based Gene Therapy Products Product and Services
        2.9.4 CSL Behring AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 CSL Behring Recent Developments/Updates
    2.10 Sangamo Therapeutics
        2.10.1 Sangamo Therapeutics Details
        2.10.2 Sangamo Therapeutics Major Business
        2.10.3 Sangamo Therapeutics AAV-based Gene Therapy Products Product and Services
        2.10.4 Sangamo Therapeutics AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Sangamo Therapeutics Recent Developments/Updates
    2.11 Biogen
        2.11.1 Biogen Details
        2.11.2 Biogen Major Business
        2.11.3 Biogen AAV-based Gene Therapy Products Product and Services
        2.11.4 Biogen AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Biogen Recent Developments/Updates
    2.12 Freeline Therapeutics
        2.12.1 Freeline Therapeutics Details
        2.12.2 Freeline Therapeutics Major Business
        2.12.3 Freeline Therapeutics AAV-based Gene Therapy Products Product and Services
        2.12.4 Freeline Therapeutics AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Freeline Therapeutics Recent Developments/Updates
    2.13 Coave Therapeutics
        2.13.1 Coave Therapeutics Details
        2.13.2 Coave Therapeutics Major Business
        2.13.3 Coave Therapeutics AAV-based Gene Therapy Products Product and Services
        2.13.4 Coave Therapeutics AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Coave Therapeutics Recent Developments/Updates
    2.14 MeiraGTx
        2.14.1 MeiraGTx Details
        2.14.2 MeiraGTx Major Business
        2.14.3 MeiraGTx AAV-based Gene Therapy Products Product and Services
        2.14.4 MeiraGTx AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 MeiraGTx Recent Developments/Updates
    2.15 RegenxBio
        2.15.1 RegenxBio Details
        2.15.2 RegenxBio Major Business
        2.15.3 RegenxBio AAV-based Gene Therapy Products Product and Services
        2.15.4 RegenxBio AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 RegenxBio Recent Developments/Updates
    2.16 Asklepios Biopharmaceutical
        2.16.1 Asklepios Biopharmaceutical Details
        2.16.2 Asklepios Biopharmaceutical Major Business
        2.16.3 Asklepios Biopharmaceutical AAV-based Gene Therapy Products Product and Services
        2.16.4 Asklepios Biopharmaceutical AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Asklepios Biopharmaceutical Recent Developments/Updates
    2.17 Audentes Therapeutics
        2.17.1 Audentes Therapeutics Details
        2.17.2 Audentes Therapeutics Major Business
        2.17.3 Audentes Therapeutics AAV-based Gene Therapy Products Product and Services
        2.17.4 Audentes Therapeutics AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 Audentes Therapeutics Recent Developments/Updates
    2.18 Neurophth
        2.18.1 Neurophth Details
        2.18.2 Neurophth Major Business
        2.18.3 Neurophth AAV-based Gene Therapy Products Product and Services
        2.18.4 Neurophth AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.18.5 Neurophth Recent Developments/Updates
    2.19 Belief BioMed
        2.19.1 Belief BioMed Details
        2.19.2 Belief BioMed Major Business
        2.19.3 Belief BioMed AAV-based Gene Therapy Products Product and Services
        2.19.4 Belief BioMed AAV-based Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.19.5 Belief BioMed Recent Developments/Updates

3 Competitive Environment: AAV-based Gene Therapy Products by Manufacturer
    3.1 Global AAV-based Gene Therapy Products Sales Quantity by Manufacturer (2019-2024)
    3.2 Global AAV-based Gene Therapy Products Revenue by Manufacturer (2019-2024)
    3.3 Global AAV-based Gene Therapy Products Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of AAV-based Gene Therapy Products by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 AAV-based Gene Therapy Products Manufacturer Market Share in 2023
        3.4.3 Top 6 AAV-based Gene Therapy Products Manufacturer Market Share in 2023
    3.5 AAV-based Gene Therapy Products Market: Overall Company Footprint Analysis
        3.5.1 AAV-based Gene Therapy Products Market: Region Footprint
        3.5.2 AAV-based Gene Therapy Products Market: Company Product Type Footprint
        3.5.3 AAV-based Gene Therapy Products Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global AAV-based Gene Therapy Products Market Size by Region
        4.1.1 Global AAV-based Gene Therapy Products Sales Quantity by Region (2019-2030)
        4.1.2 Global AAV-based Gene Therapy Products Consumption Value by Region (2019-2030)
        4.1.3 Global AAV-based Gene Therapy Products Average Price by Region (2019-2030)
    4.2 North America AAV-based Gene Therapy Products Consumption Value (2019-2030)
    4.3 Europe AAV-based Gene Therapy Products Consumption Value (2019-2030)
    4.4 Asia-Pacific AAV-based Gene Therapy Products Consumption Value (2019-2030)
    4.5 South America AAV-based Gene Therapy Products Consumption Value (2019-2030)
    4.6 Middle East & Africa AAV-based Gene Therapy Products Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global AAV-based Gene Therapy Products Sales Quantity by Type (2019-2030)
    5.2 Global AAV-based Gene Therapy Products Consumption Value by Type (2019-2030)
    5.3 Global AAV-based Gene Therapy Products Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global AAV-based Gene Therapy Products Sales Quantity by Application (2019-2030)
    6.2 Global AAV-based Gene Therapy Products Consumption Value by Application (2019-2030)
    6.3 Global AAV-based Gene Therapy Products Average Price by Application (2019-2030)

7 North America
    7.1 North America AAV-based Gene Therapy Products Sales Quantity by Type (2019-2030)
    7.2 North America AAV-based Gene Therapy Products Sales Quantity by Application (2019-2030)
    7.3 North America AAV-based Gene Therapy Products Market Size by Country
        7.3.1 North America AAV-based Gene Therapy Products Sales Quantity by Country (2019-2030)
        7.3.2 North America AAV-based Gene Therapy Products Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe AAV-based Gene Therapy Products Sales Quantity by Type (2019-2030)
    8.2 Europe AAV-based Gene Therapy Products Sales Quantity by Application (2019-2030)
    8.3 Europe AAV-based Gene Therapy Products Market Size by Country
        8.3.1 Europe AAV-based Gene Therapy Products Sales Quantity by Country (2019-2030)
        8.3.2 Europe AAV-based Gene Therapy Products Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific AAV-based Gene Therapy Products Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific AAV-based Gene Therapy Products Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific AAV-based Gene Therapy Products Market Size by Region
        9.3.1 Asia-Pacific AAV-based Gene Therapy Products Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific AAV-based Gene Therapy Products Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America AAV-based Gene Therapy Products Sales Quantity by Type (2019-2030)
    10.2 South America AAV-based Gene Therapy Products Sales Quantity by Application (2019-2030)
    10.3 South America AAV-based Gene Therapy Products Market Size by Country
        10.3.1 South America AAV-based Gene Therapy Products Sales Quantity by Country (2019-2030)
        10.3.2 South America AAV-based Gene Therapy Products Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa AAV-based Gene Therapy Products Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa AAV-based Gene Therapy Products Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa AAV-based Gene Therapy Products Market Size by Country
        11.3.1 Middle East & Africa AAV-based Gene Therapy Products Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa AAV-based Gene Therapy Products Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 AAV-based Gene Therapy Products Market Drivers
    12.2 AAV-based Gene Therapy Products Market Restraints
    12.3 AAV-based Gene Therapy Products Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of AAV-based Gene Therapy Products and Key Manufacturers
    13.2 Manufacturing Costs Percentage of AAV-based Gene Therapy Products
    13.3 AAV-based Gene Therapy Products Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 AAV-based Gene Therapy Products Typical Distributors
    14.3 AAV-based Gene Therapy Products Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global AAV-based Gene Therapy Products Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global AAV-based Gene Therapy Products Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. uniQure Basic Information, Manufacturing Base and Competitors
 Table 4. uniQure Major Business
 Table 5. uniQure AAV-based Gene Therapy Products Product and Services
 Table 6. uniQure AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. uniQure Recent Developments/Updates
 Table 8. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 9. Spark Therapeutics Major Business
 Table 10. Spark Therapeutics AAV-based Gene Therapy Products Product and Services
 Table 11. Spark Therapeutics AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Spark Therapeutics Recent Developments/Updates
 Table 13. AveXis (Novartis) Basic Information, Manufacturing Base and Competitors
 Table 14. AveXis (Novartis) Major Business
 Table 15. AveXis (Novartis) AAV-based Gene Therapy Products Product and Services
 Table 16. AveXis (Novartis) AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. AveXis (Novartis) Recent Developments/Updates
 Table 18. PTC Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 19. PTC Therapeutics Major Business
 Table 20. PTC Therapeutics AAV-based Gene Therapy Products Product and Services
 Table 21. PTC Therapeutics AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. PTC Therapeutics Recent Developments/Updates
 Table 23. BioMarin Basic Information, Manufacturing Base and Competitors
 Table 24. BioMarin Major Business
 Table 25. BioMarin AAV-based Gene Therapy Products Product and Services
 Table 26. BioMarin AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. BioMarin Recent Developments/Updates
 Table 28. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 29. Sarepta Therapeutics Major Business
 Table 30. Sarepta Therapeutics AAV-based Gene Therapy Products Product and Services
 Table 31. Sarepta Therapeutics AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Sarepta Therapeutics Recent Developments/Updates
 Table 33. Roche Basic Information, Manufacturing Base and Competitors
 Table 34. Roche Major Business
 Table 35. Roche AAV-based Gene Therapy Products Product and Services
 Table 36. Roche AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. Roche Recent Developments/Updates
 Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
 Table 39. Pfizer Major Business
 Table 40. Pfizer AAV-based Gene Therapy Products Product and Services
 Table 41. Pfizer AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. Pfizer Recent Developments/Updates
 Table 43. CSL Behring Basic Information, Manufacturing Base and Competitors
 Table 44. CSL Behring Major Business
 Table 45. CSL Behring AAV-based Gene Therapy Products Product and Services
 Table 46. CSL Behring AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 47. CSL Behring Recent Developments/Updates
 Table 48. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 49. Sangamo Therapeutics Major Business
 Table 50. Sangamo Therapeutics AAV-based Gene Therapy Products Product and Services
 Table 51. Sangamo Therapeutics AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 52. Sangamo Therapeutics Recent Developments/Updates
 Table 53. Biogen Basic Information, Manufacturing Base and Competitors
 Table 54. Biogen Major Business
 Table 55. Biogen AAV-based Gene Therapy Products Product and Services
 Table 56. Biogen AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 57. Biogen Recent Developments/Updates
 Table 58. Freeline Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 59. Freeline Therapeutics Major Business
 Table 60. Freeline Therapeutics AAV-based Gene Therapy Products Product and Services
 Table 61. Freeline Therapeutics AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 62. Freeline Therapeutics Recent Developments/Updates
 Table 63. Coave Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 64. Coave Therapeutics Major Business
 Table 65. Coave Therapeutics AAV-based Gene Therapy Products Product and Services
 Table 66. Coave Therapeutics AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 67. Coave Therapeutics Recent Developments/Updates
 Table 68. MeiraGTx Basic Information, Manufacturing Base and Competitors
 Table 69. MeiraGTx Major Business
 Table 70. MeiraGTx AAV-based Gene Therapy Products Product and Services
 Table 71. MeiraGTx AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 72. MeiraGTx Recent Developments/Updates
 Table 73. RegenxBio Basic Information, Manufacturing Base and Competitors
 Table 74. RegenxBio Major Business
 Table 75. RegenxBio AAV-based Gene Therapy Products Product and Services
 Table 76. RegenxBio AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. RegenxBio Recent Developments/Updates
 Table 78. Asklepios Biopharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 79. Asklepios Biopharmaceutical Major Business
 Table 80. Asklepios Biopharmaceutical AAV-based Gene Therapy Products Product and Services
 Table 81. Asklepios Biopharmaceutical AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 82. Asklepios Biopharmaceutical Recent Developments/Updates
 Table 83. Audentes Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 84. Audentes Therapeutics Major Business
 Table 85. Audentes Therapeutics AAV-based Gene Therapy Products Product and Services
 Table 86. Audentes Therapeutics AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 87. Audentes Therapeutics Recent Developments/Updates
 Table 88. Neurophth Basic Information, Manufacturing Base and Competitors
 Table 89. Neurophth Major Business
 Table 90. Neurophth AAV-based Gene Therapy Products Product and Services
 Table 91. Neurophth AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 92. Neurophth Recent Developments/Updates
 Table 93. Belief BioMed Basic Information, Manufacturing Base and Competitors
 Table 94. Belief BioMed Major Business
 Table 95. Belief BioMed AAV-based Gene Therapy Products Product and Services
 Table 96. Belief BioMed AAV-based Gene Therapy Products Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 97. Belief BioMed Recent Developments/Updates
 Table 98. Global AAV-based Gene Therapy Products Sales Quantity by Manufacturer (2019-2024) & (Units)
 Table 99. Global AAV-based Gene Therapy Products Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 100. Global AAV-based Gene Therapy Products Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 101. Market Position of Manufacturers in AAV-based Gene Therapy Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 102. Head Office and AAV-based Gene Therapy Products Production Site of Key Manufacturer
 Table 103. AAV-based Gene Therapy Products Market: Company Product Type Footprint
 Table 104. AAV-based Gene Therapy Products Market: Company Product Application Footprint
 Table 105. AAV-based Gene Therapy Products New Market Entrants and Barriers to Market Entry
 Table 106. AAV-based Gene Therapy Products Mergers, Acquisition, Agreements, and Collaborations
 Table 107. Global AAV-based Gene Therapy Products Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 108. Global AAV-based Gene Therapy Products Sales Quantity by Region (2019-2024) & (Units)
 Table 109. Global AAV-based Gene Therapy Products Sales Quantity by Region (2025-2030) & (Units)
 Table 110. Global AAV-based Gene Therapy Products Consumption Value by Region (2019-2024) & (USD Million)
 Table 111. Global AAV-based Gene Therapy Products Consumption Value by Region (2025-2030) & (USD Million)
 Table 112. Global AAV-based Gene Therapy Products Average Price by Region (2019-2024) & (US$/Unit)
 Table 113. Global AAV-based Gene Therapy Products Average Price by Region (2025-2030) & (US$/Unit)
 Table 114. Global AAV-based Gene Therapy Products Sales Quantity by Type (2019-2024) & (Units)
 Table 115. Global AAV-based Gene Therapy Products Sales Quantity by Type (2025-2030) & (Units)
 Table 116. Global AAV-based Gene Therapy Products Consumption Value by Type (2019-2024) & (USD Million)
 Table 117. Global AAV-based Gene Therapy Products Consumption Value by Type (2025-2030) & (USD Million)
 Table 118. Global AAV-based Gene Therapy Products Average Price by Type (2019-2024) & (US$/Unit)
 Table 119. Global AAV-based Gene Therapy Products Average Price by Type (2025-2030) & (US$/Unit)
 Table 120. Global AAV-based Gene Therapy Products Sales Quantity by Application (2019-2024) & (Units)
 Table 121. Global AAV-based Gene Therapy Products Sales Quantity by Application (2025-2030) & (Units)
 Table 122. Global AAV-based Gene Therapy Products Consumption Value by Application (2019-2024) & (USD Million)
 Table 123. Global AAV-based Gene Therapy Products Consumption Value by Application (2025-2030) & (USD Million)
 Table 124. Global AAV-based Gene Therapy Products Average Price by Application (2019-2024) & (US$/Unit)
 Table 125. Global AAV-based Gene Therapy Products Average Price by Application (2025-2030) & (US$/Unit)
 Table 126. North America AAV-based Gene Therapy Products Sales Quantity by Type (2019-2024) & (Units)
 Table 127. North America AAV-based Gene Therapy Products Sales Quantity by Type (2025-2030) & (Units)
 Table 128. North America AAV-based Gene Therapy Products Sales Quantity by Application (2019-2024) & (Units)
 Table 129. North America AAV-based Gene Therapy Products Sales Quantity by Application (2025-2030) & (Units)
 Table 130. North America AAV-based Gene Therapy Products Sales Quantity by Country (2019-2024) & (Units)
 Table 131. North America AAV-based Gene Therapy Products Sales Quantity by Country (2025-2030) & (Units)
 Table 132. North America AAV-based Gene Therapy Products Consumption Value by Country (2019-2024) & (USD Million)
 Table 133. North America AAV-based Gene Therapy Products Consumption Value by Country (2025-2030) & (USD Million)
 Table 134. Europe AAV-based Gene Therapy Products Sales Quantity by Type (2019-2024) & (Units)
 Table 135. Europe AAV-based Gene Therapy Products Sales Quantity by Type (2025-2030) & (Units)
 Table 136. Europe AAV-based Gene Therapy Products Sales Quantity by Application (2019-2024) & (Units)
 Table 137. Europe AAV-based Gene Therapy Products Sales Quantity by Application (2025-2030) & (Units)
 Table 138. Europe AAV-based Gene Therapy Products Sales Quantity by Country (2019-2024) & (Units)
 Table 139. Europe AAV-based Gene Therapy Products Sales Quantity by Country (2025-2030) & (Units)
 Table 140. Europe AAV-based Gene Therapy Products Consumption Value by Country (2019-2024) & (USD Million)
 Table 141. Europe AAV-based Gene Therapy Products Consumption Value by Country (2025-2030) & (USD Million)
 Table 142. Asia-Pacific AAV-based Gene Therapy Products Sales Quantity by Type (2019-2024) & (Units)
 Table 143. Asia-Pacific AAV-based Gene Therapy Products Sales Quantity by Type (2025-2030) & (Units)
 Table 144. Asia-Pacific AAV-based Gene Therapy Products Sales Quantity by Application (2019-2024) & (Units)
 Table 145. Asia-Pacific AAV-based Gene Therapy Products Sales Quantity by Application (2025-2030) & (Units)
 Table 146. Asia-Pacific AAV-based Gene Therapy Products Sales Quantity by Region (2019-2024) & (Units)
 Table 147. Asia-Pacific AAV-based Gene Therapy Products Sales Quantity by Region (2025-2030) & (Units)
 Table 148. Asia-Pacific AAV-based Gene Therapy Products Consumption Value by Region (2019-2024) & (USD Million)
 Table 149. Asia-Pacific AAV-based Gene Therapy Products Consumption Value by Region (2025-2030) & (USD Million)
 Table 150. South America AAV-based Gene Therapy Products Sales Quantity by Type (2019-2024) & (Units)
 Table 151. South America AAV-based Gene Therapy Products Sales Quantity by Type (2025-2030) & (Units)
 Table 152. South America AAV-based Gene Therapy Products Sales Quantity by Application (2019-2024) & (Units)
 Table 153. South America AAV-based Gene Therapy Products Sales Quantity by Application (2025-2030) & (Units)
 Table 154. South America AAV-based Gene Therapy Products Sales Quantity by Country (2019-2024) & (Units)
 Table 155. South America AAV-based Gene Therapy Products Sales Quantity by Country (2025-2030) & (Units)
 Table 156. South America AAV-based Gene Therapy Products Consumption Value by Country (2019-2024) & (USD Million)
 Table 157. South America AAV-based Gene Therapy Products Consumption Value by Country (2025-2030) & (USD Million)
 Table 158. Middle East & Africa AAV-based Gene Therapy Products Sales Quantity by Type (2019-2024) & (Units)
 Table 159. Middle East & Africa AAV-based Gene Therapy Products Sales Quantity by Type (2025-2030) & (Units)
 Table 160. Middle East & Africa AAV-based Gene Therapy Products Sales Quantity by Application (2019-2024) & (Units)
 Table 161. Middle East & Africa AAV-based Gene Therapy Products Sales Quantity by Application (2025-2030) & (Units)
 Table 162. Middle East & Africa AAV-based Gene Therapy Products Sales Quantity by Country (2019-2024) & (Units)
 Table 163. Middle East & Africa AAV-based Gene Therapy Products Sales Quantity by Country (2025-2030) & (Units)
 Table 164. Middle East & Africa AAV-based Gene Therapy Products Consumption Value by Country (2019-2024) & (USD Million)
 Table 165. Middle East & Africa AAV-based Gene Therapy Products Consumption Value by Country (2025-2030) & (USD Million)
 Table 166. AAV-based Gene Therapy Products Raw Material
 Table 167. Key Manufacturers of AAV-based Gene Therapy Products Raw Materials
 Table 168. AAV-based Gene Therapy Products Typical Distributors
 Table 169. AAV-based Gene Therapy Products Typical Customers


List of Figures
 Figure 1. AAV-based Gene Therapy Products Picture
 Figure 2. Global AAV-based Gene Therapy Products Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global AAV-based Gene Therapy Products Revenue Market Share by Type in 2023
 Figure 4. AAV2 Examples
 Figure 5. AAV8 Examples
 Figure 6. AAV9 Examples
 Figure 7. Others Examples
 Figure 8. Global AAV-based Gene Therapy Products Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 9. Global AAV-based Gene Therapy Products Revenue Market Share by Application in 2023
 Figure 10. Haematology Examples
 Figure 11. Ophthalmology Examples
 Figure 12. Neurology Examples
 Figure 13. Musculoskeletal Examples
 Figure 14. Others Examples
 Figure 15. Global AAV-based Gene Therapy Products Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 16. Global AAV-based Gene Therapy Products Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 17. Global AAV-based Gene Therapy Products Sales Quantity (2019-2030) & (Units)
 Figure 18. Global AAV-based Gene Therapy Products Price (2019-2030) & (US$/Unit)
 Figure 19. Global AAV-based Gene Therapy Products Sales Quantity Market Share by Manufacturer in 2023
 Figure 20. Global AAV-based Gene Therapy Products Revenue Market Share by Manufacturer in 2023
 Figure 21. Producer Shipments of AAV-based Gene Therapy Products by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 22. Top 3 AAV-based Gene Therapy Products Manufacturer (Revenue) Market Share in 2023
 Figure 23. Top 6 AAV-based Gene Therapy Products Manufacturer (Revenue) Market Share in 2023
 Figure 24. Global AAV-based Gene Therapy Products Sales Quantity Market Share by Region (2019-2030)
 Figure 25. Global AAV-based Gene Therapy Products Consumption Value Market Share by Region (2019-2030)
 Figure 26. North America AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 27. Europe AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 28. Asia-Pacific AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 29. South America AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 30. Middle East & Africa AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 31. Global AAV-based Gene Therapy Products Sales Quantity Market Share by Type (2019-2030)
 Figure 32. Global AAV-based Gene Therapy Products Consumption Value Market Share by Type (2019-2030)
 Figure 33. Global AAV-based Gene Therapy Products Average Price by Type (2019-2030) & (US$/Unit)
 Figure 34. Global AAV-based Gene Therapy Products Sales Quantity Market Share by Application (2019-2030)
 Figure 35. Global AAV-based Gene Therapy Products Revenue Market Share by Application (2019-2030)
 Figure 36. Global AAV-based Gene Therapy Products Average Price by Application (2019-2030) & (US$/Unit)
 Figure 37. North America AAV-based Gene Therapy Products Sales Quantity Market Share by Type (2019-2030)
 Figure 38. North America AAV-based Gene Therapy Products Sales Quantity Market Share by Application (2019-2030)
 Figure 39. North America AAV-based Gene Therapy Products Sales Quantity Market Share by Country (2019-2030)
 Figure 40. North America AAV-based Gene Therapy Products Consumption Value Market Share by Country (2019-2030)
 Figure 41. United States AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 42. Canada AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 43. Mexico AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 44. Europe AAV-based Gene Therapy Products Sales Quantity Market Share by Type (2019-2030)
 Figure 45. Europe AAV-based Gene Therapy Products Sales Quantity Market Share by Application (2019-2030)
 Figure 46. Europe AAV-based Gene Therapy Products Sales Quantity Market Share by Country (2019-2030)
 Figure 47. Europe AAV-based Gene Therapy Products Consumption Value Market Share by Country (2019-2030)
 Figure 48. Germany AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 49. France AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 50. United Kingdom AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 51. Russia AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 52. Italy AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 53. Asia-Pacific AAV-based Gene Therapy Products Sales Quantity Market Share by Type (2019-2030)
 Figure 54. Asia-Pacific AAV-based Gene Therapy Products Sales Quantity Market Share by Application (2019-2030)
 Figure 55. Asia-Pacific AAV-based Gene Therapy Products Sales Quantity Market Share by Region (2019-2030)
 Figure 56. Asia-Pacific AAV-based Gene Therapy Products Consumption Value Market Share by Region (2019-2030)
 Figure 57. China AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 58. Japan AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 59. South Korea AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 60. India AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 61. Southeast Asia AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 62. Australia AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 63. South America AAV-based Gene Therapy Products Sales Quantity Market Share by Type (2019-2030)
 Figure 64. South America AAV-based Gene Therapy Products Sales Quantity Market Share by Application (2019-2030)
 Figure 65. South America AAV-based Gene Therapy Products Sales Quantity Market Share by Country (2019-2030)
 Figure 66. South America AAV-based Gene Therapy Products Consumption Value Market Share by Country (2019-2030)
 Figure 67. Brazil AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 68. Argentina AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 69. Middle East & Africa AAV-based Gene Therapy Products Sales Quantity Market Share by Type (2019-2030)
 Figure 70. Middle East & Africa AAV-based Gene Therapy Products Sales Quantity Market Share by Application (2019-2030)
 Figure 71. Middle East & Africa AAV-based Gene Therapy Products Sales Quantity Market Share by Country (2019-2030)
 Figure 72. Middle East & Africa AAV-based Gene Therapy Products Consumption Value Market Share by Country (2019-2030)
 Figure 73. Turkey AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 74. Egypt AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 75. Saudi Arabia AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 76. South Africa AAV-based Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 77. AAV-based Gene Therapy Products Market Drivers
 Figure 78. AAV-based Gene Therapy Products Market Restraints
 Figure 79. AAV-based Gene Therapy Products Market Trends
 Figure 80. Porters Five Forces Analysis
 Figure 81. Manufacturing Cost Structure Analysis of AAV-based Gene Therapy Products in 2023
 Figure 82. Manufacturing Process Analysis of AAV-based Gene Therapy Products
 Figure 83. AAV-based Gene Therapy Products Industrial Chain
 Figure 84. Sales Channel: Direct to End-User vs Distributors
 Figure 85. Direct Channel Pros & Cons
 Figure 86. Indirect Channel Pros & Cons
 Figure 87. Methodology
 Figure 88. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

uniQure
Spark Therapeutics
AveXis (Novartis)
PTC Therapeutics
BioMarin
Sarepta Therapeutics
Roche
Pfizer
CSL Behring
Sangamo Therapeutics
Biogen
Freeline Therapeutics
Coave Therapeutics
MeiraGTx
RegenxBio
Asklepios Biopharmaceutical
Audentes Therapeutics
Neurophth
Belief BioMed

Related Reports

Global AAV-based Gene Therapy Products Supply, Demand and Key Producers, 2024-2030

Global AAV-based Gene Therapy Products Supply, Demand and Key Producers, 2024-2030

date 28 Apr 2024

date Pharma & Healthcare

AAV-based gene therapy products utilize adeno-associated virus (AAV) vectors as delivery vehicles to transfer therapeutic genes into target cells for the treatment of various genetic disorders and diseases. AAV vectors are non-pathogenic viruses that can efficiently infect a wide range of cells and have a low immunogenicity profile, making them suitable candidates for gene therapy applications. In AAV-based gene therapy, the therapeutic gene of interest is inserted into the AAV vector's genome, and the vector is then administered to the patient, typically via intravenous injection or direct injection into the affected tissue. Once inside the target cells, the AAV vector delivers the therapeutic gene, allowing it to be expressed and produce the desired therapeutic protein. AAV-based gene therapy products hold significant promise for the treatment of inherited genetic disorders, as well as acquired diseases such as certain types of cancer and neurodegenerative disorders, offering potential long-term therapeutic benefits with a single administration.

Product Tags

AAV-based Gene Therapy Products

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>